CN1310936C - Industrial process for preparing beta-thymidine - Google Patents

Industrial process for preparing beta-thymidine Download PDF

Info

Publication number
CN1310936C
CN1310936C CNB2004100902505A CN200410090250A CN1310936C CN 1310936 C CN1310936 C CN 1310936C CN B2004100902505 A CNB2004100902505 A CN B2004100902505A CN 200410090250 A CN200410090250 A CN 200410090250A CN 1310936 C CN1310936 C CN 1310936C
Authority
CN
China
Prior art keywords
thymidine
beta
reaction
ribose
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2004100902505A
Other languages
Chinese (zh)
Other versions
CN1634959A (en
Inventor
吴发明
宁向阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Pharmaceutical Co., Ltd.
Original Assignee
Zhejiang Shaxing Pharma & Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Shaxing Pharma & Chemical Co Ltd filed Critical Zhejiang Shaxing Pharma & Chemical Co Ltd
Priority to CNB2004100902505A priority Critical patent/CN1310936C/en
Publication of CN1634959A publication Critical patent/CN1634959A/en
Application granted granted Critical
Publication of CN1310936C publication Critical patent/CN1310936C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Saccharide Compounds (AREA)

Abstract

The present invention relates to a four-step synthetic method of the industrial preparation of beta-thymidine, which belongs to the medical midbody field. The four-step synthetic method is characterized in that D-ribose is used as starting raw materials which are firstly directly condensed with thymine, the D-ribose carries out halogenation-acylation reaction with propionyl chloride and is reduced by catalytic hydrogenation, and finally, the D-ribose is converted to the beta-thymidine by catalytic alcoholysis, and a total yield is larger than 65%.

Description

The industrial production process of beta-thymidine
Technical field
The invention belongs to the medicine intermediate field, relate to a kind of industrial production process of beta-thymidine.
Background technology
(β-Thymidine), claim deoxythymidine (Deoxythymidine) again is the key intermediate of treatment acquired immune deficiency syndrome (AIDS) (AIDS) the neat many furans pyridine of medicine (Zidovodine) to beta-thymidine.At present, the preparation method of beta-thymidine mainly contains chemical synthesis, DNA enzymolysis process, fermentation method and 4 kinds of methods of enzyme process.At present, use having of chemical synthesis: the US4914233 (applying date: on March 1st, 1988) disclose a kind of method that changes into beta-thymidine with α, β four-O-acyl ribose, this method starting raw material is difficult for obtaining, and a, beta comfiguration proportioning raw materials be difficult for grasping, and stereoselectivity is poor; CN1055293 (the applying date: on October 6th, 1998) narrated and a kind ofly go on foot synthesis method with thymus pyrimidine and α, β-tetrem acyl-D-ribose condensation under the Louis acid catalysis effect, alcoholysis, halo one acylations, catalytic hydrogenation and alcoholysis five through protection, this method starting raw material adopts α, β-tetrem acyl-D-ribose, through condensation, alcoholysis prepares the 5-methyluridine, complex process, and the condensation catalyst employing is expensive and acid is torn in Louis that be difficult for reclaiming, and route is long, yield is low, the cost height; (applying date: on May 30th, 1994) relating to a kind of is the method for feedstock production beta-thymidine with the wooden thymidine without protection, adopts propionyl bromide in halo one acylations process, and yield is low, and equipment corrosion is serious at US5596087.
Summary of the invention
The objective of the invention is to overcome the defective of prior art, adopt novel starting raw material, a kind of economy, simple, the preparation method that cleans, be applicable to suitability for industrialized production are provided.The present invention adopts four step chemical synthesiss, is starting raw material with D-ribose, through condensation, halo one acylations, and the catalytic hydrogenation reduction, catalyzed alcoholysis prepares beta-thymidine, and its synthetic route is as follows:
Figure C20041009025000051
5-methyluridine (IV), condensation generation 5-methyl-2 under existing document (CN1055293) employing tetrem acyl ribose and the katalysis of thymus pyrimidine at anhydrous stannic chloride through protecting ', 3 ', 5 '-O-triacetyl-β-D-ribose, make through alcoholysis, route is long again, and yield is low, the cost height, and the tin tetrachloride contaminated wastewater is serious; We adopt with D-ribose is raw material, under the katalysis of acid, makes with the direct condensation of thymus pyrimidine.The consumption of D-ribose (II) is 0.8-1.3 times (mol ratio) of thymus pyrimidine (III), and preferably 0.9-1.1 doubly; Catalyzer is the vitriol oil, oleum, and consumption is 3-1O times (mol ratio) of thymus pyrimidine (III), and preferably 4-6 doubly; Dropping temperature is-10--40 ℃, and preferably 0--30 ℃; Reaction solvent is methylene dichloride, chloroform, ethyl acetate, toluene, dimethylbenzene, hexane, acetonitrile, DMF; Reaction times is 2-20 hour, preferably 8-12 hour.This reaction stereoselectivity is strong, and the content of beta isomer is more than 99%.
2 '-halo-2 '-deoxidation-5-methyl-3 ', 5 '-O-alkyloyl-β-D-ribose uridine (V), existing document (US5596087) adopts 5-methyluridine (IV) and propionyl bromide generation halo one acylation reaction to make, and propionyl bromide price height, equipment corrosion is serious; We adopt propionyl chloride to make halo one acylting agent, the yield height, and cost is low.The consumption of propionyl chloride is 2-8 times (mol ratio) of 5-methyluridine (IV), and preferably 3-6 doubly; Reaction solvent is selected from acetonitrile, ethyl acetate, and methyl propionate, toluene, dimethylbenzene, hexane, methylene dichloride, DMF can be single solvents, also can be mixed solvents; Temperature of reaction is 30--90 ℃, is preferably 50--70 ℃; Reaction times is 1-10 hour, preferably 2-6 hour.
2 '-deoxidation-5-methyl-3 '; 5 '-O-alkyloyl-β-D ribose uridine (VI), make in following condition: under the A. normal pressure, 2 '-halo-2 '-deoxidation-5-methyl-3 '; 5 '-the logical hydrogen blistering reaction under catalyst action of O-alkyloyl-β-D-ribose uridine (V), the logical hydrogen of B. is to 2-5 * 10 5Pa, 2 '-halo-2 '-deoxidation-5-methyl-3 ', 5 '-O-alkyloyl-β-D-ribose uridine (V) reacts under catalyst action.Catalyzer comprises Ru/c, Pd/c, Pd/CaCO 3, Pd/BaSO 4, PdCl 2, Raney-Ni and nickel alloy catalyst, catalyst consumption is the 1-6 doubly (mol ratio) of compound (V), preferably 3-5 doubly; Reaction solvent comprises methyl alcohol, ethanol, benzene, toluene, chloroform, methylene dichloride, methanol, ethanol/water, benzene/water, toluene, chloroform/water, methylene dichloride/water; In order to keep the potential of hydrogen of reaction system, must add a certain amount of sodium-acetate, sodium bicarbonate, yellow soda ash; Temperature of reaction 10--50 ℃, preferably 20--30 ℃; Reaction times is 2-20 hour, preferably 3-6 hour.
Beta-thymidine (I), by 2 '-deoxidation-5-methyl-3 ', 5 '-O-alkyloyl-β-D ribose uridine (VI) makes through catalyzed alcoholysis.Alcoholysis reagent comprises methyl alcohol, ethanol, propyl alcohol, Virahol, butanols; Catalyzer comprises ammonia, sodium methylate, sodium hydroxide, potassium hydroxide, sodium bicarbonate, sodium carbonate; Temperature of reaction is 0--60 ℃, preferably 20--30 ℃; Reaction times is 5-30 hour, preferably 10-15 hour.
The present invention has overcome the defective that prior art exists, and is starting raw material with D-ribose, directly is condensed into the 5-methyluridine under the katalysis of the vitriol oil, shortens synthetic route; Make halo one acylting agent with propionyl chloride, production technique is simple, mild condition, and product yield is higher, and production cost is reduced greatly, is adapted to suitability for industrialized production.
Embodiment
Example 1:
Having agitator, thermometer, add D-ribose 15g (0.1mol) in the 250ml there-necked flask of dropping funnel, methylene dichloride 150ml, be stirred to dissolving, add thymus pyrimidine 12.5g again, (0.1mol), be cooled to below 10 ℃, the vitriol oil 12ml of dropping 98.5%, finish, be warming up to 20-25 ℃ naturally, stirring reaction 10 hours, add water, stir layering, the water layer dichloromethane extraction merges organic layer, steaming vibrating dichloromethane, ethyl alcohol recrystallization gets off-white color 5-methyluridine 23g, content (HPLC): 99.2%, and fusing point: 181-185 ℃: yield: 89.14%.
Example 2:
In the there-necked flask of the 500ml that has agitator, thermometer, add acetonitrile 150ml; propionyl chloride 30g (0.42mol); be warming up to 50 ℃; add 5-methyluridine 20g (0.077mol), 60 ℃ of insulated and stirred were reacted 3 hours, steamed acetonitrile in batches; cooling; add water 200ml, be cooled to below 5 ℃, insulated and stirred 2 hours; suction filtration; the washing, drying, faint yellow solid 2 '-chloro-2 '-deoxidation-5-methyl-3 '; 5 '-O-alkyloyl-β-D-ribose uridine 28g; fusing point: 132-134 ℃, content (HPLC): 97.3%, yield: 93%.
Example 3:
In autoclave, add 2 '-chloro-2 '-deoxidation-5-methyl 4-3 ', 5 '-O-alkyloyl-β-D-ribose uridine 39g (0.1mol), add methanol (1: 0.3) 400ml; sodium-acetate 12.5g (0.15mol); stirring and dissolving adds Pd/C40g, logical hydrogen to 3 * 10 5Pa, 25--30 ℃ of reaction 4 hours, elimination catalyzer, concentrating under reduced pressure got thick thing, are directly used in the next step.
Example 4:
Charging capacity such as example 3, logical hydrogen blistering under the normal pressure, 25--30 ℃ of reaction 5 hours, concentrating under reduced pressure got thick thing, is directly used in the next step.
Example 5:
In having the 500ml there-necked flask of agitator, thermometer, add the whole products of embodiment 3 gained, add ammonia/methyl alcohol (7%) 250ml, 20-30 ℃ of stirring reaction 10 hours concentrates, ethyl alcohol recrystallization, filter, vacuum-drying gets beta-thymidine 19g, fusing point: 185--190 ℃, [α]=+ 17.5--+19.1 ° (c=3, H 2O), content (HPLC): 98.5%, yield: 87%.
Example 6:
Have in the 500ml there-necked flask of agitator, thermometer, add total overall reaction product in the example 4, add methyl alcohol 250ml, add sodium methylate methanol solution (28%) 4ml, stirring reaction 8 hours, concentrate, ethyl alcohol recrystallization filters, vacuum-drying gets thymidine 20g, fusing point: 185--190 ℃, [α]=+ 17.5--+19.1 ° (c=3, H 2O), content (HPLC): 98.5%, yield: 92%.

Claims (5)

1, a kind of industrial production process of beta-thymidine is characterized in that with D-ribose be starting raw material, earlier with the direct condensation of thymus pyrimidine; carry out halo-acylation reaction with propionyl chloride again; through the catalytic hydrogenation reduction, after catalyzed alcoholysis is converted into beta-thymidine, its synthetic route is as follows then:
Figure C2004100902500002C1
RCO in the above synthetic route represents alkyloyl,
Concrete steps are:
(1) directly reacts by D-ribose (II) and be converted into 5-methyluridine (IV) with thymus pyrimidine (III) catalyzing and condensing;
(2) compound (IV) by halo-acylation reaction be converted into 2 '-halo-2 '-deoxidation-5-methyl-3 ', 5 '-O-alkyloyl-β-D-ribose uridine (V);
(3) compound (V) by the catalytic hydrogenation reduction reaction be converted into 2 '-deoxidation-5-methyl-3 ', 5 '-O-alkyloyl-β-D-ribose uridine (VI);
(4) compound (VI) obtains beta-thymidine (I) by alcoholysis reaction in the presence of catalyzer.
2, beta-thymidine industrial production process as claimed in claim 1 is characterized in that in halo-acylation reaction, halo-acylting agent is selected propionyl chloride for use; Reaction solvent is a kind of in following these solvents: acetonitrile, ethyl acetate, methyl propionate, toluene, dimethylbenzene, hexane, methylene dichloride, DMF.
3, beta-thymidine industrial production process as claimed in claim 1 is characterized in that the catalytic hydrogenation reduction reaction carries out under one of following condition: under the A. normal pressure, and logical hydrogen blistering reaction under catalyst action; B. logical hydrogen to 2 * 1O 5Pa-5 * 10 5Pa reacts under catalyst action, and the catalyzer in " A ", " B " condition is selected from Ru/c, Pd/c, Pd/CaCO 3, Pd/BaSO 4, PdCl 2, Raney-Ni and nickel alloy catalyst.
4, beta-thymidine industrial production process according to claim 1 is characterized in that in the alcoholysis reaction, and alcoholysis reagent is a kind of in the following reagent: methyl alcohol, ethanol, propyl alcohol, Virahol, butanols.
5, the beta-thymidine industrial production process described in claim 1 is characterized in that in the alcoholysis reaction with a kind of catalyzer of doing in the following reagent: ammonia, sodium methylate, sodium hydroxide, potassium hydroxide, sodium bicarbonate, yellow soda ash.
CNB2004100902505A 2004-10-28 2004-10-28 Industrial process for preparing beta-thymidine Expired - Fee Related CN1310936C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2004100902505A CN1310936C (en) 2004-10-28 2004-10-28 Industrial process for preparing beta-thymidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2004100902505A CN1310936C (en) 2004-10-28 2004-10-28 Industrial process for preparing beta-thymidine

Publications (2)

Publication Number Publication Date
CN1634959A CN1634959A (en) 2005-07-06
CN1310936C true CN1310936C (en) 2007-04-18

Family

ID=34847587

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004100902505A Expired - Fee Related CN1310936C (en) 2004-10-28 2004-10-28 Industrial process for preparing beta-thymidine

Country Status (1)

Country Link
CN (1) CN1310936C (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2356246B1 (en) * 2008-11-14 2012-08-22 Csir Biocatalytic preparation of 5-methyluridine
CN101555266B (en) * 2009-05-25 2011-11-30 上海医药工业研究院 Preparation method of Tibifuding
CN102050857B (en) * 2010-12-08 2012-05-02 浙江先锋科技有限公司 Method for synthesizing 5-methyluridine
CN102180925B (en) * 2011-03-22 2013-05-08 苏州迪马生物科技发展有限公司 Method for treating emulsion layer in process for synthesizing 5-methyluridine
CN103450302B (en) * 2012-05-29 2016-09-21 上海迪赛诺药业有限公司 The method preparing beta-thymidine
CN106117287B (en) * 2016-04-14 2019-10-29 安达市海纳贝尔化工有限公司 The method for preparing 5- methyl deoxyuridine
CN106831916B (en) * 2017-02-06 2019-12-06 抚州市星辰药业有限公司 synthetic method of beta-thymidine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596087A (en) * 1994-05-20 1997-01-21 Council Of Scientific & Industrial Research Process for the preparation of beta thymidine
CN1216766A (en) * 1998-10-06 1999-05-19 中国人民解放军第二军医大学 Method for preparing beta-thymidine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596087A (en) * 1994-05-20 1997-01-21 Council Of Scientific & Industrial Research Process for the preparation of beta thymidine
CN1216766A (en) * 1998-10-06 1999-05-19 中国人民解放军第二军医大学 Method for preparing beta-thymidine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
司他夫定的合成 靳立人等,厦门大学学报 自然科学版,第41卷第2期 2002 *

Also Published As

Publication number Publication date
CN1634959A (en) 2005-07-06

Similar Documents

Publication Publication Date Title
CN1310936C (en) Industrial process for preparing beta-thymidine
CN102086222A (en) Preparation method of beta-thymidine
CN102086165B (en) Application of Pd catalyst in hydrogenation process for producing doxycycline
CN102603820B (en) Preparation method of 4, 6-dibenzyl 2, 3-unsaturated glucoside
CN113248557A (en) Method for synthesizing cholesterol by taking BA as raw material
CN102030627B (en) Process for recovering valued compounds from a stream derived from purification of methyl methacrylate
CN1687003A (en) Method for synthesizing phenyloxalate from dicthyl oxalate and phenol
CN111559995B (en) Preparation process of ascorbic acid ethyl ether
CN114014903B (en) Synthesis method of ergosterol and derivatives thereof
CN102295623B (en) Method for preparing N-acetylmorpholine by using ketene
CN111196793A (en) Preparation method of 2, 5-furan dicarboxylic acid dialkyl ester
CN103497120B (en) Process for synthesizing diatrizoic acid by using solid-phase load method
CN1166608C (en) Three-phase phase-transfer catalytic synthesis process of 9,9-dimethoxyl methyl) fluorene
CN101412739B (en) Production process of beta-glucose pentaacetate
CN102001930B (en) Method for purifying chloroacetic acid by catalytic hydrogenolysis in chloroacetic acid production and application thereof
CN101006039A (en) Method for producing 2-(4-fluoro-benzyl)-phenyl-acetic acid
CN101434539A (en) Preparation of benzyl acetate
CN108675918B (en) Synthesis method of piceatannol
CN102503823A (en) Synthesis process for fatty acyl citrate compound
CN1086691C (en) Process for preparing malononitrile
CN113980081B (en) Process for the preparation of ergosterol and derivatives thereof
CN112358514A (en) Synthesis process of arbutin
CN110026217A (en) A kind of application of more molybdic acid catalyst of argentiferous in oxycellulose
CN112898368B (en) Preparation method of obeticholic acid intermediate
JP3884494B2 (en) Method for producing cellotriose and cellotetraose monomers and oligomers therefrom

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Assignee: Zhejiang Xianfeng Chemistry Co., Ltd.

Assignor: Zhejiang Shaxing Pharma & Chemical Co., Ltd.

Contract record no.: 2010330000664

Denomination of invention: Industrial process for preparing beta-thymidine

Granted publication date: 20070418

License type: Exclusive License

Open date: 20050706

Record date: 20100428

EM01 Change of recordation of patent licensing contract

Change date: 20110707

Contract record no.: 2010330000664

Assignee after: Zhejiang Xianfeng Technology Co., Ltd.

Assignee before: Zhejiang Xianfeng Chemistry Co., Ltd.

C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: 317021, Zhejiang City, Linhai City, Yongquan Town after the Yellow River reef head

Patentee after: Zhejiang Pharmaceutical Co., Ltd.

Address before: 317021, Zhejiang City, Linhai City, Yongquan Town after the Yellow River reef head

Patentee before: Zhejiang Shaxing Pharma & Chemical Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070418

Termination date: 20161028